Walgreens Boots Alliance, Inc. (WBA) Shares Bought by IBM Retirement Fund

IBM Retirement Fund boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 88.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,903 shares of the pharmacy operator’s stock after acquiring an additional 10,729 shares during the period. IBM Retirement Fund’s holdings in Walgreens Boots Alliance were worth $2,004,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Reilly Financial Advisors LLC increased its position in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after buying an additional 100 shares during the period. Hudock Capital Group LLC increased its position in Walgreens Boots Alliance by 0.4% during the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock worth $108,000 after buying an additional 5 shares during the period. Tarbox Group Inc. increased its position in Walgreens Boots Alliance by 288.3% during the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares during the period. Webster Bank N. A. increased its position in Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares during the period. Finally, Orrstown Financial Services Inc. increased its position in Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 213 shares during the period. Institutional investors and hedge funds own 60.18% of the company’s stock.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Shares Bought by IBM Retirement Fund” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://ledgergazette.com/2017/09/17/ibm-retirement-fund-acquires-10729-shares-of-walgreens-boots-alliance-inc-wba.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 82.50 on Friday. The stock’s 50 day moving average price is $81.26 and its 200-day moving average price is $81.99. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $89.69. The firm has a market capitalization of $88.28 billion, a price-to-earnings ratio of 20.83 and a beta of 1.26.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating the consensus estimate of $1.30 by $0.03. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.18 EPS. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were given a dividend of $0.40 per share. The ex-dividend date was Wednesday, August 16th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a dividend yield of 1.94%. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

Walgreens Boots Alliance declared that its Board of Directors has approved a stock repurchase plan on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its shares are undervalued.

Several research analysts have weighed in on WBA shares. Morgan Stanley reiterated an “overweight” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Loop Capital began coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target on the stock. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $91.81.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply